Completed Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer NCT00454363 Conditions Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +44 more Locations Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States Dana-Farber Cancer Institute — Boston, Massachusetts, United States M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
Completed Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma NCT01204476 Conditions Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +52 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
